https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-23 / BMC Cancer 2004 Aug;4:53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-23 / BMC Cancer 2004 Aug;4:532004-08-23 00:00:002004-08-23 00:00:00The impact of surgery and mild hyperthermia on tumor response and angioneogenesis of malignant melanoma in a rat perfusion model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-15 / Clin. Cancer Res. 2004 Aug;10(16):5316-26
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-15 / Clin. Cancer Res. 2004 Aug;10(16):5316-262004-08-15 00:00:002019-02-15 08:47:00Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-05 / Proc. Natl. Acad. Sci. U.S.A. 2004 Oct;101 Suppl 2:14653-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-05 / Proc. Natl. Acad. Sci. U.S.A. 2004 Oct;101 Suppl 2:14653-62004-08-05 00:00:002019-02-15 08:48:24Therapeutic cancer vaccines: using unique antigens
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-01 / Int. J. Mol. Med. 2004 Aug;14(2):295-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-01 / Int. J. Mol. Med. 2004 Aug;14(2):295-92004-08-01 00:00:002019-02-15 08:37:49Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-01 / J. Clin. Virol. 2004 Aug;30(4):283-90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-01 / J. Clin. Virol. 2004 Aug;30(4):283-902004-08-01 00:00:002019-02-15 08:37:50Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-01 / Ai Zheng 2004 Aug;23(8):910-3
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-01 / Ai Zheng 2004 Aug;23(8):910-32004-08-01 00:00:002019-02-15 09:20:00[Antitumor research on mouse melanoma with combined application of Newcastle disease virus and its HN gene]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-08-01 / Int. J. Oncol. 2004 Aug;25(2):293-302
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-08-01 / Int. J. Oncol. 2004 Aug;25(2):293-3022004-08-01 00:00:002020-06-23 09:41:28High cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of F and fusion promotion activity of HN molecules
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-07-15 / J. Clin. Oncol. 2004 Jul;22(14):2808-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-07-15 / J. Clin. Oncol. 2004 Jul;22(14):2808-152004-07-15 00:00:002019-02-15 08:45:37Autologous dendritic cell vaccines for non-small-cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-07-15 / Cancer Res. 2004 Jul;64(14):4973-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-07-15 / Cancer Res. 2004 Jul;64(14):4973-92004-07-15 00:00:002019-02-15 08:47:00Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-07-15 / Clin. Cancer Res. 2004 Jul;10(14):4699-708
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-07-15 / Clin. Cancer Res. 2004 Jul;10(14):4699-7082004-07-15 00:00:002004-07-15 00:00:00Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses
